Skip to main content
. Author manuscript; available in PMC: 2013 Feb 5.
Published in final edited form as: Eur J Cancer. 2012 Jul 4;48(17):3215–3222. doi: 10.1016/j.ejca.2012.05.021

TABLE 1.

Patients characteristics (N=131)

No. of Patients %
Age onset
Adult (≥ 30 years) 106 81.0
Young adult (≥ 18 and < 30 years) 4 16.0
Children (<18 years) 21 4.0
Sex
Male 70 53.5
Female 61 46.5
Tumor site
Small bowel 57 76.5
Stomach 42 15.0
Other 32 8.5
Mutational status
KIT Exon 11 66 50.5
KIT Exon 9 23 17.5
KIT Exon 13 1 0.5
PDGFRA 9 7.0
Wild-type 32 24.5
Treatment status
Imatinib-naïve 78 59.5
Imatinib-responsive 10 7.5
Imatinib-resistant 43 33.0